The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
Abstract
BACKGROUND: Delayed treatment of candidemia has previously been shown to be an important determinant of patient outcome. However, septic shock attributed to Candida infection and its determinants of outcome have not been previously evaluated in a large patient population. METHODS: A retrospective cohort study of hospitalized patients with septic shock and blood cultures positive for Candida species was conducted at Barnes-Jewish Hospital, a 1250-bed urban teaching hospital (January 2002-December 2010). RESULTS: Two hundred twenty-four consecutive patients with septic shock and a positive blood culture for Candida species were identified. Death during hospitalization occurred among 155 (63.5%) patients. The hospital mortality rate for patients having adequate source control and antifungal therapy administered within 24 hours of the onset of shock was 52.8% (n = 142), compared to a mortality rate of 97.6% (n = 82) in patients who did not have these goals attained (P < .001). Multivariate logistic regression analysis demonstrated that delayed antifungal treatment (adjusted odds ratio [AOR], 33.75; 95% confidence interval [CI], 9.65-118.04; P = .005) and failure to achieve timely source control (AOR, 77.40; 95% CI, 21.52-278.38; P = .001) were independently associated with a greater risk of hospital mortality. CONCLUSIONS: The risk of death is exceptionally high among patients with septic shock attributed to Candida infection. Efforts aimed at timely source control and antifungal treatment are likely to be associated with improved clinical outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sepsis and septic shock due to fungi are most commonly observed in ICUs and are associated with poor outcomes [166–170].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [167]
In the citing paper
“Some observational studies suggested that prompt initiation of appropriate empiric antifungal therapy may be associated with a reduction in mortality, however these studies do not prove a causal relationship between antifungal therapy and outcome, nor do they clarify the role of timing of treatment, and some other studies have failed to show this association [167, 171–173].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [167]
In the citing paper
“This association is particularly pronounced for patients with candidemia and septic shock, for whom initiation of antifungal treatment more than 24 h after the onset of shock is associated with a mortality rate of nearly 100% [73].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [73]
In the citing paper
“There is compelling evidence that CVC removal is associated with higher rates of treatment success and lower mortality rates as compared with CVC retention [73,84,88,96,97].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [73]
Citations
Cites
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Self-citationInternational Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Self-citation
Research works printed but not linked: 1
- Guzman, 2011, 3, 65
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationPappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Mylonakis, E., Clancy, C. J., Ostrosky-Zeichner, L., Garey, K. W., Alangaden, G. J., Vazquez, J. A., Groeger, J. S., Judson, M. A., Vinagre, Y.-M., Heard, S. O., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu959 · Cited by 443
Invasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2014) · Virulence · doi:10.4161/viru.26187 · Cited by 372
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud-Ndam, L., Wolff, M., Fontanet, A., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 312
Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J. M., Zaragoza, R., Montejo, M., Muñoz, P., Ruiz-Camps, I., Cuenca-Estrella, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12380 · Cited by 299
McCarty, T. P., & Pappas, P. G. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.013 · Cited by 285
A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.
Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3310-z · Cited by 284
Candidemia and Invasive Candidiasis
McCarty, T. P., White, C. M., & Pappas, P. G. (2021) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2021.03.007 · Cited by 260
Candidemia and invasive candidiasis in adults: A narrative review
Antinori, S., Milazzo, L., Sollima, S., Galli, M., & Corbellino, M. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.06.029 · Cited by 257
Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs
Bauer, K. A., Perez, K. K., Forrest, G. N., & Goff, D. A. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu547 · Cited by 250
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients
Martin-Loeches, I., Antonelli, M., Cuenca-Estrella, M., Dimopoulos, G., Einav, S., De Waele, J. J., Garnacho-Montero, J., Kanj, S. S., Machado, F. R., Montravers, P., et al. (2019) · Intensive Care Medicine · doi:10.1007/s00134-019-05599-w · Cited by 235
Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Scarparo, C., Antonelli, M., Garnacho-Montero, J., Diaz-Martin, A., Palacios-Garcia, I., Luzzati, R., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3866-2 · Cited by 208
Risk Factors for Invasive Candida Infection in Critically Ill Patients
Thomas-Rüddel, D. O., Schlattmann, P., Pletz, M., Kurzai, O., & Bloos, F. (2022) · CHEST · doi:10.1016/j.chest.2021.08.081 · Cited by 203
Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference
Sartelli, M., Catena, F., Abu-Zidan, F. M., Ansaloni, L., Biffl, W. L., Boermeester, M. A., Ceresoli, M., Chiara, O., Coccolini, F., De Waele, J. J., et al. (2017) · World Journal of Emergency Surgery · doi:10.1186/s13017-017-0132-7 · Cited by 199
Timsit, J.-F., Azoulay, E., Schwebel, C., Charles, P. E., Cornet, M., Souweine, B., Klouche, K., Jaber, S., Trouillet, J.-L., Bruneel, F., et al. (2016) · JAMA · doi:10.1001/jama.2016.14655 · Cited by 198
Bassetti, M., Marchetti, M., Chakrabarti, A., Colizza, S., Garnacho-Montero, J., Kett, D. H., Munoz, P., Cristini, F., Andoniadou, A., Viale, P., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3109-3 · Cited by 198
Thompson, G. R., Soriano, A., Cornely, O. A., Kullberg, B. J., Kollef, M., Vazquez, J., Honore, P. M., Bassetti, M., Pullman, J., Chayakulkeeree, M., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02324-8 · Cited by 192
Self-citationInvasive candidiasis: current clinical challenges and unmet needs in adult populations
Soriano, A., Honore, P. M., Puerta-Alcalde, P., Garcia-Vidal, C., Pagotto, A., Gonçalves-Bradley, D. C., & Verweij, P. E. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad139 · Cited by 190
Risk factors for candidemia: a prospective matched case-control study
FUNGINOS, T., Poissy, J., Groups, A. F. S., Damonti, L., Bignon, A., Khanna, N., Von Kietzell, M., Boggian, K., Neofytos, D., Vuotto, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2766-1 · Cited by 188
Intensive care medicine research agenda on invasive fungal infection in critically ill patients
Bassetti, M., Garnacho-Montero, J., Calandra, T., Kullberg, B., Dimopoulos, G., Azoulay, E., Chakrabarti, A., Kett, D., Leon, C., Ostrosky-Zeichner, L., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4731-2 · Cited by 183
Invasive candidiasis in critical care: challenges and future directions
Logan, C., Martin-Loeches, I., & Bicanic, T. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06240-x · Cited by 180
Initial antimicrobial management of sepsis
Niederman, M. S., Baron, R. M., Bouadma, L., Calandra, T., Daneman, N., DeWaele, J., Kollef, M. H., Lipman, J., & Nair, G. B. (2021) · Critical Care · doi:10.1186/s13054-021-03736-w · Cited by 180
Self-citationDiagnosis and Treatment of Invasive Candidiasis
Barantsevich, N., & Barantsevich, E. (2022) · Antibiotics · doi:10.3390/antibiotics11060718 · Cited by 178
Candida albicans, plasticity and pathogenesis
Poulain, D. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.813904 · Cited by 173
Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*
Puig‐Asensio, M., Pemán, J., Zaragoza, R., Garnacho‐Montero, J., Martín‐Mazuelos, E., Cuenca‐Estrella, M., & Almirante, B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000221 · Cited by 167
Clancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1095 · Cited by 165
Timing of antibiotic therapy in the ICU
Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021) · Critical Care · doi:10.1186/s13054-021-03787-z · Cited by 161
Self-citationNosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
Sherry, L., Rajendran, R., Lappin, D. F., Borghi, E., Perdoni, F., Falleni, M., Tosi, D., Smith, K., Williams, C., Jones, B., et al. (2014) · BMC Microbiology · doi:10.1186/1471-2180-14-182 · Cited by 153
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Host response toCandida albicansbloodstream infection and sepsis
Duggan, S., Leonhardt, I., Hünniger, K., & Kurzai, O. (2015) · Virulence · doi:10.4161/21505594.2014.988096 · Cited by 141
The risk and clinical outcome of candidemia depending on underlying malignancy
The French Mycoses Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Desnos‐Ollivier, M., Bretagne, S., & Dromer, F. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4743-y · Cited by 140
Nicolle, L. E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.014 · Cited by 138
Obeng, A. O., Egelund, E. F., Alsultan, A., Peloquin, C. A., & Johnson, J. A. (2014) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1400 · Cited by 137
Florio, W., Tavanti, A., Barnini, S., Ghelardi, E., & Lupetti, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01097 · Cited by 134
Guillamet, C. V., Scolari, M., Zilberberg, M. D., Shorr, A. F., Micek, S. T., & Kollef, M. H. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000516 · Cited by 129
Self-citationCandidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 122
Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study
Bassetti, M., Merelli, M., Ansaldi, F., de Florentiis, D., Sartor, A., Scarparo, C., Callegari, A., & Righi, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127534 · Cited by 118
Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
León, C., Ostrosky-Zeichner, L. L., & Schuster, M. G. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3281-0 · Cited by 117
Candida albicans infection and intestinal immunity
Tong, Y., & Tang, J. (2017) · Microbiological Research · doi:10.1016/j.micres.2017.02.002 · Cited by 116
Garnacho‐Montero, J., Díaz‐Martín, A., García-Cabrera, E., de Pipaón, M. R. P., Hernandez-Caballero, C., & Lepe, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks347 · Cited by 116
Xiao, M., Chen, S. C.-A., Kong, F., Xu, X.-L., Yan, L., Kong, H.-S., Fan, X., Hou, X., Cheng, J.-W., Zhou, M.-L., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz573 · Cited by 115
What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead
Bassetti, M., Righi, E., Montravers, P., & Cornely, O. A. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx445 · Cited by 115
Xiao, M., Sun, Z., Kang, M., Guo, D., Liao, K., Chen, S. C.-A., Kong, F., Fan, X., Cheng, J., Hou, X., et al. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00577-18 · Cited by 114
Reynolds, D., Burnham, J. P., Guillamet, C. V., McCabe, M., Yuenger, V., Betthauser, K. D., Micek, S. T., & Kollef, M. H. (2022) · European Respiratory Review · doi:10.1183/16000617.0068-2022 · Cited by 113
Self-citationGamaletsou, M. N., Walsh, T. J., Zaoutis, T., Pagoni, M., Kotsopoulou, M., Voulgarelis, M., Panayiotidis, P., Vassilakopoulos, T., Angelopoulou, M. K., Marangos, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12312 · Cited by 112
“Previous studies have shown that increased APACHE II score at the onset of candidaemia is a clinical predictor for progression to septic shock [19] and is independently associated with higher hospital mortality [18,20].”
BackgroundResultTreatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
Amornphimoltham, P., Yuen, P. S. T., Star, R. A., & Leelahavanichkul, A. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05581-y · Cited by 109
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
Leroy, O., Bailly, S., Gangneux, J.-P., Mira, J.-P., Devos, P., Dupont, H., Montravers, P., Perrigault, P.-F., Constantin, J.-M., Guillemot, D., et al. (2016) · Annals of Intensive Care · doi:10.1186/s13613-015-0103-7 · Cited by 102
The current treatment landscape: Candidiasis
Bassetti, M., Peghin, M., & Timsit, J.-F. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw392 · Cited by 99
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 99
Strength in numbers: antifungal strategies against fungal biofilms
Ramage, G., Robertson, S. N., & Williams, C. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.023 · Cited by 99
The leaky gut and the gut microbiome in sepsis – targets in research and treatment
Chancharoenthana, W., Kamolratanakul, S., Schultz, M. J., & Leelahavanichkul, A. (2023) · Clinical Science · doi:10.1042/cs20220777 · Cited by 96
Candidemia in the elderly: What does it change?
Barchiesi, F., Orsetti, E., Mazzanti, S., Trave, F., Salvi, A., Nitti, C., & Manso, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176576 · Cited by 95
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M., Williams, C., Munro, C. A., Jones, B., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 94
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
“Due to the limitation of laboratory diagnostics, various clinical prediction rules are proposed to identify the patients likely to have IC [88].”
BackgroundBilal, H., Shafiq, M., Hou, B., Islam, R., Khan, M. N., Khan, R. U., & Zeng, Y. (2022) · Virulence · doi:10.1080/21505594.2022.2123325 · Cited by 91
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cortegiani, A., Russotto, V., Maggiore, A., Attanasio, M., Naro, A. R., Raineri, S. M., & Giarratano, A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004920.pub3 · Cited by 91
for the S-TAFE study group, Rouzé, A., Loridant, S., Poissy, J., Dervaux, B., Sendid, B., Cornu, M., & Nseir, S. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4932-8 · Cited by 88
Hünniger, K., Lehnert, T., Bieber, K., Martin, R., Figge, M. T., & Kurzai, O. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003479 · Cited by 87
Farmakiotis, D., Kyvernitakis, A., Tarrand, J. J., & Kontoyiannis, D. P. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.07.006 · Cited by 86
Mylonakis, E. E., Zacharioudakis, I. M., Clancy, C. J., Nguyen, M. H., & Pappas, P. G. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01756-17 · Cited by 83
Posteraro, B., Tumbarello, M., PASCALE, G. D., Liberto, E., Vallecoccia, M. S., Carolis, E. D., Gravio, V. D., Trecarichi, E. M., Sanguinetti, M., & Antonelli, M. M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw112 · Cited by 82
Bassetti, M., Peghin, M., Carnelutti, A., Righi, E., Merelli, M., Ansaldi, F., Trucchi, C., Alicino, C., Sartor, A., Toniutto, P., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4717-0 · Cited by 78
Epidemiology of invasive candidiasis in a surgical intensive care unit: an observational study
Aguilar, G., Delgado, C., Corrales, I., Izquierdo, A. C., Gracia, E., Moreno, T., Romero, E., Ferrando, C., Carbonell, J., Borrás, R., et al. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1458-4 · Cited by 77
Management bundles for candidaemia: the impact of compliance on clinical outcomes
Takesue, Y., Ueda, T., Mikamo, H., Oda, S., Takakura, S., Kitagawa, Y., KOHNO, S., on behalf of the ACTIONs Project, Masuda, A., Yoshida, C., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku414 · Cited by 77
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 77
Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance
Kotey, F. C. N., Dayie, N. T. K. D., Tetteh‐Quarcoo, P. B., & Donkor, E. S. (2021) · Infectious Diseases Research and Treatment · doi:10.1177/11786337211026927 · Cited by 76
Extracellular DNA release confers heterogeneity in Candida albicans biofilm formation
Rajendran, R., Sherry, L., Lappin, D. F., Nile, C. J., Smith, K., Williams, C., Munro, C. A., & Ramage, G. (2014) · BMC Microbiology · doi:10.1186/s12866-014-0303-6 · Cited by 76
Righi, E. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i38.4311 · Cited by 76
Hirano, R., Sakamoto, Y., Kudo, K., & Ohnishi, M. (2015) · Infection and Drug Resistance · doi:10.2147/idr.s80677 · Cited by 74
Idelevich, E. A., Grunewald, C. M., Wüllenweber, J., & Becker, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114834 · Cited by 74
Ghrenassia, E., Mokart, D., Mayaux, J., Demoule, A., Rezine, I., Kerhuel, L., Calvet, L., JONG, A. D., Azoulay, É., & Darmon, M. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0539-2 · Cited by 73
Diagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 71
Bailly, S., Leroy, O., Montravers, P., Constantin, J., Dupont, H., Guillemot, D., Lortholary, O., Mira, J. P., Pérrigault, P.-F., Gangneux, J., et al. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-4053-1 · Cited by 71
Gautier‐Veyret, E., Fonrose, X., Tonini, J., Thiébaut, A., Bartoli, M., Quésada, J.-L., Bulabois, C., Cahn, J.-Y. Y., & Stanke‐Labesque, F. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04838-14 · Cited by 71
Pfaller, M. A., Messer, S. A., Rhomberg, P. R., & Castanheira, M. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.03.028 · Cited by 70
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Kamath, S., Altaq, H. H., & Abdo, T. (2023) · Microorganisms · doi:10.3390/microorganisms11092231 · Cited by 68
Garnacho‐Montero, J., Díaz‐Martín, A., Cantón‐Bulnes, M. L., Ramírez, P., Sierra, R., Arias-Verdú, D., Rodríguez-Delgado, M., Loza-Vázquez, A., Rodriguez-Gomez, J., Gordón, M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002867 · Cited by 67
Hsu, J., Lai, M., Lee, C., Chu, S., Wu, I.-H., Huang, H., Lee, I., Chiang, M., Fu, R.-H., & Tsai, M.-H. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3100-2 · Cited by 67
Castanheira, M., Messer, S. A., Jones, R. N., Farrell, D. J., & Pfaller, M. A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.06.007 · Cited by 66
Bloos, F., Held, J., Kluge, S., Simon, P., Kogelmann, K., de Heer, G., Kuhn, S., Jarczak, D., Motsch, J., Hempel, G., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06733-x · Cited by 66
Are the Statins promising antifungal agents against invasive candidiasis?
Lima, W. G., Alves-Nascimento, L. A., Andrade, J. T., Vieira, L., de Azambuja Ribeiro, R. I. M., Thomé, R. G., dos Santos, H. B., Ferreira, J. M. S., & Soares, A. C. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.076 · Cited by 65
Simon, S. P., Li, R., Silver, M. P., Andrade, J., Tharian, B., Fu, L. H., Villanueva, D. M., Abascal, D. G., Mayer, A., Truong, J. Q., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac735 · Cited by 65
Improving the management of candidemia through antimicrobial stewardship interventions
Reed, E. E., West, J. E., Keating, E. A., Pancholi, P., Balada-Llasat, J.-M., Mangino, J. E., Bauer, K. A. A., & Goff, D. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.012 · Cited by 65
Failure of Empirical Systemic Antifungal Therapy in Mechanically Ventilated Critically Ill Patients
Bailly, S., Bouadma, L., Azoulay, É., Garrouste-Orgeas, M., Adrie, C., Souweine, B., Schwebel, C., Maubon, D., Hamidfar-Roy, R., Darmon, M., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1701oc · Cited by 63
Liposomal amphotericin B—the present
Maertens, J. A., Pagano, L., Azoulay, É., & Warris, A. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac352 · Cited by 61
Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
Bays, D. J., & Thompson, G. R. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.006 · Cited by 61
Duggan, S., Essig, F., Hünniger, K., Mokhtari, Z., Bauer, L., Lehnert, T., Brandes, S., Häder, A., Jacobsen, I. D., Martin, R., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12443 · Cited by 60
Integrating Candida albicans metabolism with biofilm heterogeneity by transcriptome mapping
Rajendran, R., May, A., Sherry, L., Kean, R., Williams, C., Jones, B., Burgess, K., Heringa, J., Abeln, S., Brandt, B. W., et al. (2016) · Scientific Reports · doi:10.1038/srep35436 · Cited by 59
Kobayashi, T., Marra, A. R., Schweizer, M. L., Eyck, P. T., Wu, C., Alzunitan, M. A., Salinas, J. L., Siegel, M., Farmakiotis, D., Auwaerter, P. G., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa270 · Cited by 59
The Economic Impact of Rapid Candida Species Identification by T2Candida Among High-Risk Patients
Bilir, S. P., Ferrufino, C. P., Pfaller, M. A., & Munakata, J. (2015) · Future Microbiology · doi:10.2217/fmb.15.29 · Cited by 58
Falcone, M., Tiseo, G., Tascini, C., Russo, A., Sozio, E., Raponi, G., Rosin, C., Pignatelli, P., Carfagna, P., Farcomeni, A., et al. (2017) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2017.03.005 · Cited by 58
Metadata
- Authors
- Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A.
- Affiliations
- Washington University in St. Louis (US)
- Barnes-Jewish Hospital (US)
- BJC HealthCare (US)
- University of Manitoba (CA)
- Corresponding author
- Kollef, M.
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-15
- Volume
- 54
- Issue
- 12
- Pages
- 1739-1746
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2161872635
- Cited by
- 477
- References
- 40
- Citations by year
- 2026: 23 · 2025: 30 · 2024: 24 · 2023: 30 · 2022: 35 · 2021: 48 · 2020: 35 · 2019: 35 · 2018: 40 · 2017: 50 · 2016: 32 · 2015: 40 · 2014: 32 · 2013: 17 · 2012: 5
- FWCI
- 20.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- septic shock, candidiasis, candidemia, empirical antifungal therapy, source control, in-hospital mortality, bloodstream infection, treatment timing
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antifungal Agents, Blood, Candida, Candidiasis, Female, Hospitals, Teaching, Humans, Male, Middle Aged, Retrospective Studies, Shock, Septic, Urban Population, Cohort Studies, Survival Analysis, Treatment Outcome, Infection Control
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.